Streetbeat News

Analyst Ratings

EYPT

HC Wainwright & Co. analyst Yi Chen maintains a Buy rating on EyePoint Pharmaceuticals (NASDAQ:EYPT) and raises the price target from $25 to $27.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:21 am

ALIM

HC Wainwright & Co. analyst Yi Chen maintains a Buy rating on Alimera Sciences (NASDAQ:ALIM) but lowers the price target from $9 to $5.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:20 am

EGHT

Needham analyst Ryan Koontz reiterates a Buy rating on 8x8 (NASDAQ:EGHT) and maintains a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:17 am

NEXCF

HC Wainwright & Co. analyst Scott Buck reiterates a Buy rating on NexTech3D.AI (OTC:NEXCF) and maintains a $2.5 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:17 am

SYBX

HC Wainwright & Co. analyst Ed Arce reiterated a Buy rating on Synlogic (NASDAQ:SYBX) and maintained a $5 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:15 am

TERN

HC Wainwright & Co. analyst Ed Arce reiterates a Neutral rating on Terns Pharma (NASDAQ:TERN) and maintains an $11 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:14 am

BLCO

HC Wainwright & Co. analyst Yi Chen maintains a Buy rating on Bausch & Lomb (NYSE:BLCO) and raises the price target from $19 to $22.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:14 am

DZSI

Needham analyst Ryan Koontz reiterated a Buy rating on DZS (NASDAQ:DZSI) and maintained a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:12 am

CALX

Needham analyst Ryan Koontz has reiterated a Buy rating on Calix (NYSE:CALX) and maintained an $88 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:11 am

ADTN

Needham analyst Ryan Koontz reiterates a Buy rating on Adtran (NASDAQ:ADTN) and maintains a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 10:10 am